Tech Nation + BioTech Nation + Global BioEntrepreneurship
Weekly Public Radio Program & Podcast
Episode 26-36 Air Date: September 8, 2026
On this week’s Tech Nation, it’s always nice to have the answers, right? Well… maybe that’s not true! Moira speaks with Columbia Professor Stuart Firestein about his new book, “It Could Be Otherwise: Science in the Age of Uncertainty,” and how we can embrace the not-always-knowing. Then, a potential biotech breakthrough for the treatment of gout - a disease that affects over 13 million people around the United States alone. Dr. James Mackay of Crystalys Therapeutics tells us about their new approach as they enter Phase III trials.
Episode 26-35 Air Date: September 1, 2026
On this week’s Tech Nation, Moira speaks with Katie Prescott, author of “The Curious Case of Mike Lynch”, about a titan of the Tech world, who lost his life along with his daughter and others when his luxury yacht tragically sank off the coast of Sicily. What happened leading up to that day, and is there more to the story? Then, you may have heard of peptides, but what exactly are they? Dr. Karsten Eastman of Sethera Therapeutics explains how they work, and how Sethera plans to develop enhanced peptides to create new medicines, starting with triple-negative breast cancer.
Episode 26-34Air Date: August 25, 2026
On this week’s Tech Nation, Moira speaks with Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology, who are working on diseases of aging before they even appear. Then, Tech Nation Health Chief Correspondent, Dr. Daniel Kraft, explains why mobility is the new vital sign. And Erica Dhawan, Author of Digital Body Language, tells us how to navigate the misinterpretations of digital communication.
BioTech Nation PODCASTS

September 8, 2026

Dr. James Mackay Co-Founder, President, & CEO Crystalys Therapeutics

On this episode of BioTech Nation...Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the treatment of gout - a disease that affects more than 13 million people in the United States alone. Dr. Mackay debunks some common misconceptions surrounding the disease, and explains what Crystalys is doing to change the way doctors treat gout going forward.
September 1, 2026
Dr. Karsten Eastman Co-Founder & CEO Sethera Therapeutics
  • You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance peptides to make new medicines. Their plan: to develop a drug using enhanced peptides for Triple-Negative Breast Cancer... and they've already received funding.

The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.